To provide confirmatory data on the link between SPARC and IL-23 in patients, we evaluated IL-23 mRNA levels via semiquantitative qPCR in tumor biopsies from the prospective BC cohort, which revealed significantly increased expression of IL-23 in ECM3 + tumors (Fig. 6K). The gene discussed is IL23A; the disease is breast cancer.